New investigational drug for treatment of Myelofibrosis
- Trial ID:
- IRB-24-8484
- Marin Xavier, MD
Inclusion Criteria
Patients must:
- Be 18 years or older
Have confirmed diagnosis of Myelofibrosis
Be able to complete study questionnaires
Exclusion Criteria
Patients must not:
- Have prior therapy with any JAK inhibitor
Have prior splenectomy
Have history of solid organ transplant
Have other malignancy within the last three years
Additional Info
All treatments and physician visits during this study will take place at Prebys Cancer Center in Hillcrest.For more information search NCT#: 06479135 at www.clinicaltrials.gov
Contact Info:
- Clinical Research Services
- crsleadership@scrippshealth.org